Which hedge funds own CCCC? C4 THERAPEUTICS INC, Q2 2026 13F holders
Healthcare · Open on the interactive board
8 of the hedge funds tracked by WhaleCreep disclosed a position in CCCC (C4 THERAPEUTICS INC) in their Q2 2026 13F filings, worth $73.5m in total. The largest holder by portfolio weight is RA Capital Management at 0.3% of its book. 2 exited: Brevan Howard Capital Management, Farallon Capital Management.
8tracked managers holding
0opened this quarter
2exited this quarter
Which hedge funds hold CCCC? Current holders by portfolio weight
| Manager | As of | Weight of book | Value | Shares | Δ shares | Action |
|---|---|---|---|---|---|---|
| RA Capital Management | Q2 2026 | 0.3% | $37.4m | 8,000,000 | 0% | held |
| Citadel Advisors | Q2 2026 | 0.0% | $19.6m | 4,187,580 | 67% | added |
| Renaissance Technologies LLC | Q2 2026 | 0.0% | $5.6m | 1,189,828 | -52% | reduced |
| Bronte Capital | Q2 2026 | 0.0% | $48.3k | 10,349 | 3% | added |
| D. E. Shaw & Co | Q2 2026 | 0.0% | $8.1m | 1,740,989 | 64% | added |
| Point72 Asset Management LP | Q2 2026 | 0.0% | $812.4k | 173,965 | 3% | added |
| Marshall Wace | Q2 2026 | 0.0% | $1.1m | 227,003 | 46% | added |
| Millennium Management | Q2 2026 | 0.0% | $1.0m | 215,386 | -85% | reduced |
Exited since the previous quarter
| Manager | Prior weight | Prior value |
|---|---|---|
| Brevan Howard Capital Management | 0.0% | $243.7k |
| Farallon Capital Management | 0.0% | $73.6k |
Held in a manager's last filing on record
These managers have not filed for the latest quarter; their last disclosure is dated.
| Manager | Last filing | Weight |
|---|---|---|
| Caxton Associates | Q4 2024 | 0.0% |
How has hedge fund ownership of CCCC changed?
| Quarter | Managers holding | Combined value |
|---|---|---|
| Q2 2026 | 8 | $73.5m |
| Q1 2026 | 10 | $41.8m |
| Q4 2025 | 5 | $36.4m |
| Q3 2025 | 2 | $2.1m |
| Q2 2025 | 2 | $1.6m |
| Q1 2025 | 3 | $767.0k |
| Q4 2024 | 4 | $18.4m |
| Q3 2024 | 4 | $34.9m |
| Q2 2024 | 6 | $25.2m |
| Q1 2024 | 5 | $51.0m |
| Q4 2023 | 3 | $41.0m |
| Q3 2023 | 3 | $724.1k |
| Q2 2023 | 3 | $1.5m |
| Q1 2023 | 4 | $1.3m |
| Q4 2022 | 1 | $192.0k |
| Q3 2022 | 2 | $763.0k |
Counts every tracked manager that disclosed CCCC in that quarter's filing, including managers that have since stopped filing.